Swiss perspectives in 10 languages

Scientists develop cancer diagnosis implant

Hand and mole on arm
When too much calcium is detected, the implant triggers the production of melanin, causing a small dark mole to appear (Re-enacted montage: ETH Zurich)

Researchers in Switzerland have developed an implant that can detect common types of cancer in the body and act as an early warning system by causing a small mole to form on skin. 

A team from Zurich’s Federal Institute of Technology (ETHZ)External link have developed a prototype implant which can be inserted under the skin. It contains a network of cells which constantly monitor calcium levels in the body. Cancer can cause calcium levels to rise in the body. The implant detects when a threshold is exceeded and triggers the production of melanin, causing a small dark mole to form. 

+ How Swiss hospitals have joined forces in battle against cancer

The implant can recognise the four most common types of cancer – prostate, lung, colon and breast cancer – at a very early stage. Cancer is the main cause of death alongside cardiovascular disease in industrialised countries. However, many of those affected are only diagnosed after a tumour has developed extensively.

“Early detection increases the chance of survival significantly,” said Martin Fussenegger, Professor at the Department of Biosystems Science and Engineering at ETHZ in Basel. If breast cancer is detected early, for example, the chance of recovery is 98%. However, if the tumour is diagnosed too late, only one in four women has a good chance of recovery.

The implant is intended primarily for self-monitoring, making it very cost effective. However, the service life of such a device is limited, as encapsulated living cells last for about a year. After that, they must be inactivated and replaced.

So far, the prototype early warning device has been tested on mice and on pig skin, where it functioned reliably, the ETHZ wrote. Tests on humans are still years away.

“Continued development and clinical trials in particular are laborious and expensive, which we as a research group cannot afford,” said Fussenegger. He believes it will take another ten years of research and development for a cancer diagnosis implant to be available for sale.

The research was published in Science Translational MedicineExternal link.

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR